Table 2.
Ryr2+/+ |
Ryr2ADA/ADA |
|||
---|---|---|---|---|
Parameters | CNA-β+/+ | CNA-β−/− | CNA-β+/+ | CNA-β−/− |
HR, beats/min | 589 ± 21 | 607 ± 18 | 490 ± 18*† | 479 ± 4*† |
LVEDD, mm | 1.59 ± 0.11 | 1.44 ± 0.06 | 3.28 ± 0.24*† | 2.46 ± 0.17*†‡ |
LVESD, mm | 0.68 ± 0.06 | 0.67 ± 0.06 | 2.96 ± 0.25*† | 1.94 ± 0.15*†‡ |
FS, % | 57.0 ± 2.0 | 54.2 ± 2.8 | 10.3 ± 1.3*† | 21.4 ± 0.9*†‡ |
IVSD, mm | 0.83 ± 0.07 | 0.80 ± 0.07 | 0.84 ± 0.06 | 0.67 ± 0.08 |
IVSS, mm | 1.21 ± 0.07 | 1.21 ± 0.07 | 0.97 ± 0.06 | 0.90 ± 0.11* |
LVPWD, mm | 0.95 ± 0.04 | 0.73 ± 0.06 | 0.83 ± 0.08 | 0.81 ± 0.06 |
LVPWS, mm | 1.28 ± 0.05 | 0.96 ± 0.09* | 0.90 ± 0.09* | 1.03 ± 0.09 |
Values are means ± SE; n = 8, 5, 7, and 4 mice for Ryr2+/+/CNA-β+/+, Ryr2+/+ /CNA-β−/−, Ryr2ADA/ADA/CNA-β+/+, and Ryr2ADA/ADA/CNA-β−/− groups, respectively.
P < 0.05 compared with Ryr2+/+/CNA-β+/+;
P < 0.05 compared with Ryr2+/+/CNA-β−/−;
P < 0.05 compared with Ryr2ADA/ADA/ CNA-β+/+.